REDUCED MORTALITY RATES WITH ANTI-TUMOR NECROSIS FACTOR ALPHA DIRECTED THERAPY WHEN COMPARED TO PROLONGED CORTICOSTEROID THERAPY FOR INFLAMMATORY BOWEL DISEASE

被引：2
|
作者：
Lewis, James D.
Scott, Frank I.
Brensinger, Colleen M.
Roy, Jason A.
Osterman, Mark T.
Mamtani, Ronac
Chen, Lang
Yun, Huifeng
Xie, Fenglong
Curtis, Jeffrey R.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)30570-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
247
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 50 条
  • [21] Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
    Peter, Inga
    Dubinsky, Marla
    Bressman, Susan
    Park, Andrew
    Lu, Changyue
    Chen, Naijun
    Wang, Anthony
    JAMA NEUROLOGY, 2018, 75 (08) : 939 - 946
  • [22] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Calloway, Alexis
    Dalal, Robin
    Beaulieu, Dawn B.
    Duley, Caroline
    Annis, Kimberly
    Gaines, Lawrence
    Slaughter, Chris
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (12) : 3563 - 3567
  • [23] Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease in the Setting of Immunosuppression for Solid Organ Transplantation
    El-Nachef, Najwa
    Terdiman, Jonathan
    Mahadevan, Uma
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1210 - 1211
  • [24] The role of anti-tumor necrosis factor-α therapy in Pyoderma gangrenosum associated with inflammatory bowel disease
    Reguiai, Ziad
    Grange, Florent
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (02) : 67 - 77
  • [25] Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
    Cheon, Jae Hee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 769 - 777
  • [26] The Role of Anti-Tumor Necrosis Factor-α Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease
    Ziad Reguiaï
    Florent Grange
    American Journal of Clinical Dermatology, 2007, 8 : 67 - 77
  • [27] Pulmonary lesions in patients with inflammatory bowel disease - the baseline and under anti-tumor necrosis factor therapy
    Borisov, Sergey
    Frolova, Ksenia
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [28] Benefits and Risks of Combining Anti-tumor Necrosis Factor with Immunomodulator Therapy in Pediatric Inflammatory Bowel Disease
    Cozijnsen, Martinus A.
    Escher, Johanna C.
    Griffiths, Anne
    Turner, Dan
    de Ridder, Lissy
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (04) : 951 - 961
  • [29] Anti-Tumor Necrosis Factor Therapy and the Risk of Gestational Diabetes in Pregnant Women With Inflammatory Bowel Disease
    Cho, Yongtai
    Choi, Eun-Young
    Choi, Ahhyung
    Han, Jung Yeol
    Ye, Byong Duk
    Kim, Ju Hwan
    Shin, Ju-Young
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 241 - 250
  • [30] Effectiveness and safety of vedolizumab in pediatric inflammatory bowel disease after failure of anti-tumor necrosis factor-alpha therapy
    Khan, R.
    Thacker, K.
    Spargo, M.
    Dutt, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 201 - 201
12345